GC Ventures

GC Ventures is the corporate venture capital arm of GC (formerly Green Cross Corporation), a leading South Korean biopharmaceutical company. Based in the United States, the firm focuses on strategic investments in early-to-growth stage startups within the life sciences, healthcare, and biotechnology sectors. GC Ventures aims to foster innovation in areas such as cell and gene therapy, vaccines, and digital health to complement the parent company's core business in plasma-derived medicines and diagnostics. By providing capital and strategic guidance, the firm helps portfolio companies scale while identifying potential synergies for the broader GC group. Their investment strategy emphasizes cross-border opportunities that bridge the North American and Asian healthcare markets, leveraging GC's global infrastructure to accelerate growth.